Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Flutter Entertainment
FLUT
|
+$128M |
| 2 |
Corebridge Financial
CRBG
|
+$18.4M |
| 3 |
Samsara
IOT
|
+$17.5M |
| 4 |
Realty Income
O
|
+$14.9M |
| 5 |
Williams-Sonoma
WSM
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$891M |
| 2 |
Microsoft
MSFT
|
+$375M |
| 3 |
NVIDIA
NVDA
|
+$237M |
| 4 |
Amazon
AMZN
|
+$198M |
| 5 |
Meta Platforms (Facebook)
META
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.23% |
| 2 | Healthcare | 12.76% |
| 3 | Consumer Discretionary | 11.79% |
| 4 | Industrials | 9.51% |
| 5 | Communication Services | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Pacific Biosciences
PACB
$361M
| $1.78M | ﹤0.01% |
475,246
+6,200
| +1% | +$36.3K |
|
|
HIBB
1902
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.78M | ﹤0.01% |
23,200
-1,200
| -5% | -$86.1K |
|
1903
Vita Coco
COCO
$3.79B
| $1.78M | ﹤0.01% |
72,900
+11,700
| +19% | +$272K |
|
1904
Klaviyo
KVYO
$5.26B
| $1.78M | ﹤0.01% |
+69,700
| New | +$1.86M |
|
1905
B&G Foods
BGS
$293M
| $1.78M | ﹤0.01% |
155,200
+12,700
| +9% | +$133K |
|
1906
Matthews International
MATW
$729M
| $1.77M | ﹤0.01% |
57,096
| – | – |
|
1907
MoonLake Immunotherapeutics
MLTX
$1.4B
| $1.77M | ﹤0.01% |
35,300
| – | – |
|
1908
Deluxe
DLX
$1.1B
| $1.77M | ﹤0.01% |
86,000
| – | – |
|
|
BRSP
1909
BrightSpire Capital
BRSP
$635M
| $1.77M | ﹤0.01% |
256,200
| – | – |
|
1910
MiMedx Group
MDXG
$612M
| $1.76M | ﹤0.01% |
228,900
| – | – |
|
1911
Immunome
IMNM
$2.98B
| $1.76M | ﹤0.01% |
+71,400
| New | +$1.45M |
|
1912
Wolverine World Wide
WWW
$1.72B
| $1.76M | ﹤0.01% |
156,700
| – | – |
|
1913
Energy Recovery
ERII
$411M
| $1.75M | ﹤0.01% |
111,100
| – | – |
|
1914
Malibu Boats
MBUU
$569M
| $1.75M | ﹤0.01% |
40,500
| – | – |
|
1915
Repay Holdings
RPAY
$306M
| $1.74M | ﹤0.01% |
158,583
| – | – |
|
|
BRKL
1916
DELISTED
Brookline Bancorp
BRKL
| $1.74M | ﹤0.01% |
174,700
| – | – |
|
1917
Archer Aviation
ACHR
$5.08B
| $1.74M | ﹤0.01% |
376,600
+8,500
| +2% | +$42.7K |
|
1918
Gorman-Rupp
GRC
$2.13B
| $1.74M | ﹤0.01% |
43,947
| – | – |
|
1919
AvePoint
AVPT
$2.88B
| $1.74M | ﹤0.01% |
219,200
| – | – |
|
1920
Innoviva
INVA
$1.53B
| $1.73M | ﹤0.01% |
113,800
-1,600
| -1% | -$25.1K |
|
1921
Sabre
SABR
$908M
| $1.72M | ﹤0.01% |
711,900
+122,400
| +21% | +$411K |
|
1922
4D Molecular Therapeutics
FDMT
$598M
| $1.72M | ﹤0.01% |
53,900
+12,400
| +30% | +$316K |
|
1923
Regenxbio
RGNX
$696M
| $1.72M | ﹤0.01% |
81,500
+3,500
| +4% | +$62.3K |
|
1924
Metallus
MTUS
$899M
| $1.72M | ﹤0.01% |
77,100
| – | – |
|
1925
Vicor
VICR
$10.6B
| $1.71M | ﹤0.01% |
44,832
| – | – |
|
Similar funds
Swiss National Bank's Q1 2024 Portfolio in Review
As of Q1 2024, Swiss National Bank held 2,559 positions worth $143B, up 4.7% from $136B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Swiss National Bank withdrew a net $6.38B in Q1 2024, closing 54 positions and reducing 945 holdings. Its most notable exit was Splunk Inc, an estimated $76.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Flutter Entertainment worth $119M.
- Swiss National Bank's largest Q1 2024 buy was Flutter Entertainment: 598,808 shares worth $119M.
- Swiss National Bank added most to Realty Income in Q1 2024, an estimated $14.9M increase.
- Swiss National Bank's biggest Q1 2024 reduction was Apple, cutting an estimated $891M.
- Swiss National Bank fully exited Splunk Inc in Q1 2024, selling an estimated $76.3M.
- Swiss National Bank's ten largest holdings make up 29% of its $143B portfolio in Q1 2024.
- Swiss National Bank opened 25 new positions and closed 54 in Q1 2024.
- Swiss National Bank's portfolio value rose 4.7% quarter-over-quarter to $143B.
Based on Swiss National Bank's 13F filing for Q1 2024, filed 7 May 2024.